Lansoprazole

Cat. No.: 0225LY-1321

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Lansoprazole is a trifluoroethoxypyridyl derivative used to treat Zollinger-Ellison syndrome and stomach ulcers by inhibiting the H⁺/K⁺-exchanging ATPase in gastric parietal cells; it also acts as a brain-penetrant exosome inhibitor.

Synonym: A-65006; AG-1749; 103577-45-3; Prevacid; Limpidex; Agopton; Lanzor; Bamalite; Monolitum; Takepron; Ogastro; Prevacid SoluTab; Lansoprazol; Lanzopral; Opiren; Zoton; Lanproton; Lansopep; Lasoprol; Mesactol; Aprazol; Blason; Ketian; Lancid; Lanston; Lanz; lanzoprazole; Lansoprazolum; Prosogan; Suprecid; Compraz; Ilsatec; Lansox; Zoprol; Dakar; Ogast; Promp; Prevacid Iv; PrevOnco; Lanzol-30; AG 1749; Prevacid 24HR; Prevacid I.V.; Ogastoro; A-65006; 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole; 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole; 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole

CAS No.: 103577-45-3

Compound CID: 3883

Formula: C₁₆H₁₄F₃N₃O₂S

Formula Weight: 369.36

Specification

Relative Density: 1.5 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Lansoprazole can be used in gastroenterology research to study the inhibition of the H⁺/K⁺-ATPase pump and the regulation of gastric acid secretion.